Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-21

Clinical Trial Update: Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy (ALLY) II Trial [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on the ALLY II trial evaluating adjunct intra-arterial tenecteplase after mechanical thrombectomy in ischemic stroke; the study is in Phas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TNKASE (tenecteplase)

Snippet

Sponsor: ProMedica Health System | Conditions: Ischemic Stroke, Acute Disease | Phase 2, Phase 3 | Status: RECRUITING